Correction to: Gene expression kinetics in Sepsis After Cardiac Surgery (SACS): a multicentric prospective observational study

Abstract

Full text

Correction: J Anesth Analg Crit Care 5, 57 (2025)

https://doi.org/10.1186/s44158-025–00277−4

The original publication of this article contained 2 errors:

• Several bibliographic references in the abstract were included
• The data tabulation in table 1

The incorrect and correct information is shown in this correction article. The original article has been updated. Incorrect AbstractCorrect abstractObjectivesSurviving Sepsis Campaign (SSC) defined Sepsis as “life-threatening organ dysfunction caused by a dysregulated host response to infection” (De Backer D et al, Crit Care Med, n.d.). Sepsis remains one of the leading causes of morbidity and mortality (17–65% (De Oliveira DC, Arq Bras Cardiol Sociedade Brasileira de Cardiologia - SBC 94:352–6, 2010)) worldwide and it still remains a challenge to be defined and for which an appropriate treatment is desired (Chiu and Legrand, Curr Opin Anaesthesiol 34:71–6, 2021). Different studies have been conducted on genes coding for inflammatory cytokines whose could predispose to the development of sepsis [e.g., IL-10 PD1 and WT1] (Gupta DL et al, Infectious Process Sepsis, 202).DesignThis multicentric observational prospective study aims to evaluate blinding the genetic expression kinetics of different molecules involved in the inflammatory process, IL10, PD1 and WT1, to search for a possible molecular predictive marker of sepsis.SettingNine University teaching Hospitals in Italy take part in this study in collaboration with the Department of Applied Science (DISBA) of the University of Basilicata.ParticipantsOne hundred sixty-two patients, under elective cardiac and on pump surgery were enrolled in the study.InterventionsFrom each patient 4 blood samples were collected during and at the end of the surgery, following the study design.Measurements and main resultsWe observed, 30 min after the start of the surgery, lower gene expression levels of IL10 and PD1 in septic patients compared to non-septic (p < 0.05), but considering all the timepoint there are differences in gene expression modulation between the groups.ConclusionThese results confirmed the dysregulated immune response in septic patients compared to non-septic, highlight how a measurement of the gene expression could help to optimize procedures and pay attention to more susceptible patients.ObjectivesSurviving Sepsis Campaign (SSC) defined Sepsis as “life-threatening organ dysfunction caused by a dysregulated host response to infection”. Sepsis remains one of the leading causes of morbidity and mortality (17–65 %) worldwide and it still remains a challenge to be defined and for which an appropriate treatment is desired. Different studies have been conducted on genes coding for inflammatory cytokines whose could predispose to the development of sepsis [e.g., IL-10 PD1 and WT1].DesignThis multicentric observational prospective study aims to evaluate blinding the genetic expression kinetics of different molecules involved in the inflammatory process, IL10, PD1 and WT1, to search for a possible molecular predictive marker of sepsis. SettingNine University teaching Hospitals in Italy take part in this study in collaboration with the Department of Applied Science (DISBA) of the University of Basilicata.ParticipantsOne hundred sixty-two patients, under elective cardiac and on pump surgery were enrolled in the study.InterventionsFrom each patient 4 blood samples were collected during and at the end of the surgery, following the study design. Measurements and Main ResultsWe observed, 30 minutes after the start of the surgery, lower gene expression levels of IL10 and PD1 in septic patients compared to non-septic (p<0.05), but considering all the timepoint there are differences in gene expression modulation between the groups. ConclusionThese results confirmed the dysregulated immune response in septic patients compared to non-septic, highlight how a measurement of the gene expression could help to optimize procedures and pay attention to more susceptible patients.

Incorrect table 1 Inclusion criteria****Elective cardiac surgeryOn pump surgeryAge ≥ 18 yearsExclusion criteriaEmergency surgeryActive endocarditisPrevious sepsis or septic shockUnsigned informed consentAge < 18 years

Correct table 1 Inclusion criteriaElective cardiac surgeryOn pump surgeryAge ≥18 yearsExclusion criteriaEmergency surgeryOff pump surgeryActive endocarditisPrevious sepsis or septic shockUnsigned informed consentAge <18 years